Wasserman David A, Sorensen James L, Delucchi Kevin L, Masson Carmen L, Hall Sharon M
Department of Psychiatry, University of California-San Francisco, San Francisco, CA 94114, USA.
Psychol Addict Behav. 2006 Sep;20(3):316-21. doi: 10.1037/0893-164X.20.3.316.
The authors investigated the psychometric characteristics of the Quality of Life Interview, Brief Version (QOLI-BV; A. F. Lehman, 1995) in 126 injection drug users recruited for a clinical trial. The QOLI-BV assesses global and domain-specific quality of life. Participants completed the instrument at baseline and 3 and 6 months later. Most scales showed acceptable internal consistency. Convergent and discriminant validity were demonstrated through correlations with the SF-36, the Beck Depression Inventory, and demographic variables. Scale means rose over time, suggesting that the QOLI-BV is sensitive to change. Unexpectedly, lower baseline QOLI-BV scores predicted opiate abstinence at follow-up. The QOLI-BV appears to be an acceptable quality-of-life measure for use in clinical trials of opioid dependence treatments.
作者对126名招募参加一项临床试验的注射吸毒者，研究了生活质量访谈简版（QOLI - BV；A.F. 雷曼，1995年）的心理测量特征。QOLI - BV评估总体和特定领域的生活质量。参与者在基线时、3个月后和6个月后完成该量表。大多数量表显示出可接受的内部一致性。通过与SF - 36、贝克抑郁量表以及人口统计学变量的相关性，证明了聚合效度和区分效度。量表均值随时间上升，表明QOLI - BV对变化敏感。出乎意料的是，较低的基线QOLI - BV分数预测了随访时的阿片类药物戒断情况。QOLI - BV似乎是用于阿片类药物依赖治疗临床试验的一种可接受的生活质量测量工具。
